Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Asset Utilization Ratio (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 15 years of Asset Utilization Ratio data on record, last reported at 0.54 in Q2 2025.

  • For Q2 2025, Asset Utilization Ratio rose 5.35% year-over-year to 0.54; the TTM value through May 2025 reached 0.54, up 5.35%, while the annual FY2025 figure was 0.52, 3.37% up from the prior year.
  • Asset Utilization Ratio reached 0.54 in Q2 2025 per LFCR's latest filing, up from 0.53 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.54 in Q2 2025 and bottomed at 0.27 in Q2 2021.
  • Average Asset Utilization Ratio over 5 years is 0.43, with a median of 0.42 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: tumbled 80.73% in 2021, then soared 53.66% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.32 in 2021, then rose by 26.59% to 0.4 in 2022, then grew by 13.83% to 0.46 in 2023, then rose by 13.97% to 0.52 in 2024, then grew by 3.68% to 0.54 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.54 in Q2 2025, 0.53 in Q1 2025, and 0.52 in Q4 2024.